Company Overview of Protein Sciences Corporation
Protein Sciences Corporation develops and commercializes vaccines and biopharmaceuticals for the prevention and treatment of various diseases. The company offers vaccines that include Flublok, a recombinant protein-based seasonal influenza vaccine; Panblok, a pandemic influenza vaccine; FluNhance that is used as an additive to influenza vaccines; and SARS (D3252), which is used as an antigen for severe acute respiratory syndrome (SARS) virus. It also provides baculovirus expression vector system for prophylactic vaccines, therapeutic vaccines, gene therapy, and biologic applications; expresSF+ cells, and insect cell line that is used in the production of proteins; GeneXpress, which provides ...
1000 Research Parkway
Meriden, CT 06450
Founded in 1983
Key Executives for Protein Sciences Corporation
Head of Bioprocess Development
Head of Government and Clinical Affairs
Executive Chairman and Global Head of Business Development
Compensation as of Fiscal Year 2012.
Protein Sciences Corporation Key Developments
Protein Sciences Corporation Appoints Wayne Hachey as Company's Management as Head, Government and Clinical Affairs
Feb 20 13
Protein Sciences Corporation announced that Wayne Hachey, DO (Colonel, U.S. Army, ret.) has joined the Company's management as Head, Government and Clinical Affairs. Dr. Hachey is a physician who has dedicated 28 years of service to the military healthcare system, including six years as a subject matter expert advising senior Department of Defense (DoD) leadership regarding the DoD's vaccine policy. He was also responsible for developing the overarching DoD mitigation response to pandemic influenza and directed the implementation of that policy during the 2009 H1N1 pandemic. Most recently, Dr. Hachey served as the Chief of Public Health for the 1(st) Medical Brigade in Afghanistan where he provided public health leadership to protect over 98,000 U.S. troops. He is board certified in Public Health, Pediatrics and Neonatal-Perinatal Medicine and has won numerous awards, including the Defense Meritorious Service Medal, Meritorious Service Medal, NATO (Afghanistan) and Afghanistan Campaign Medal and Unit Combat Patch.
Protein Sciences Corporation Presents at BIO Asia International Conference 2013, Jan-29-2013
Dec 6 12
Protein Sciences Corporation Presents at BIO Asia International Conference 2013, Jan-29-2013 . Venue: Grand Hyatt Tokyo, 6-10-3 Roppongi, Minato-Ku, Tokyo 106-0032, Japan.
Protein Sciences Corporation to Invest to Establish Manufacturing Operations at Pearl River Campus in Rockland County, New York
Nov 30 12
Protein Sciences Corporation announced it signed a five year lease of manufacturing facilities with a five year renewal option and will make a multi-million dollar investment to establish manufacturing operations at Pfizer's Pearl River Campus in Rockland County, NY. The company's expansion will initially create approximately 50 new high-paying full-time jobs that could grow to up to 150 total jobs over the next decade. The company will initially lease two fully equipped buildings totaling 83,000 square feet on the 550-acre Pearl River campus that is owned and operated by Pfizer Inc. and will establish a production line for Flublok. Protein Sciences is also working with the Connecticut Department of Economic and Community Development to explore opportunities to expand the company's manufacturing operations near its headquarters in Meriden, CT.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|